A Carboxymethyl cellulose, sodium salt CEP of the European Pharmacopoeia monograph is often referred to as a Carboxymethyl cellulose, sodium salt Certificate of Suitability (COS). The purpose of a Carboxymethyl cellulose, sodium salt CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Carboxymethyl cellulose, sodium salt EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Carboxymethyl cellulose, sodium salt to their clients by showing that a Carboxymethyl cellulose, sodium salt CEP has been issued for it. The manufacturer submits a Carboxymethyl cellulose, sodium salt CEP (COS) as part of the market authorization procedure, and it takes on the role of a Carboxymethyl cellulose, sodium salt CEP holder for the record. Additionally, the data presented in the Carboxymethyl cellulose, sodium salt CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Carboxymethyl cellulose, sodium salt DMF.
A Carboxymethyl cellulose, sodium salt CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Carboxymethyl cellulose, sodium salt CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Carboxymethyl cellulose, sodium salt suppliers with CEP (COS) on PharmaCompass.